Hinge Health Targets Migraine With New Drug-Free Digital Program

SAN FRANCISCO, CA – April 29, 2026 – Digital health leader Hinge Health announced today its expansion into neurology with the launch of a comprehensive Migraine Care Program, a move that signals a significant strategic pivot from its core focus on musculoskeletal (MSK) issues. The new program aims to provide a drug-free, integrated solution for the one in six Americans who suffer from migraines, combining a proprietary wearable device, artificial intelligence, and expert-led coaching.

The announcement positions the publicly traded company to tackle a condition that costs U.S. businesses an estimated $78 billion annually in absenteeism and lost productivity. By leveraging its established digital care infrastructure, Hinge Health is betting it can replicate the success of its widely adopted MSK programs and offer a compelling new option for both patients and employers grappling with the debilitating effects of migraine.

Beyond the Pill: An Integrated, Drug-Free Approach

For decades, migraine treatment has been dominated by pharmaceutical interventions, from over-the-counter pain relievers to powerful prescription drugs like triptans and the newer class of CGRP inhibitors. While often effective, these options can come with side effects, risks of overuse headaches, and significant costs. Hinge Health's program enters this crowded market by offering a fundamentally different, multi-pronged approach that focuses on drug-free relief, management, and prevention.

At the heart of the program is Enso, a high-frequency wearable device that recently received FDA clearance for the acute treatment of migraine. The device uses transcutaneous electrical nerve stimulation (TENS) to deliver gentle electrical pulses that can reportedly reduce migraine pain in minutes. While TENS technology is not new, Hinge Health’s device is designed to be both high-frequency and non-invasive, a combination that has historically been difficult to achieve without surgical implantation. Clinical trials are currently underway to further validate Enso's efficacy specifically for migraine, building on earlier studies for MSK pain that showed users experienced an average 54.7% decrease in pain after four weeks.

“Migraine is one of the most disabling and widespread neurologic conditions, yet existing treatment options are insufficient,” said Dr. Jeffrey Krauss, Chief Medical Officer of Hinge Health, in a statement. “The FDA recently cleared our proprietary Enso device for the treatment of migraine, enabling us to deliver a first-of-its-kind care solution that combines groundbreaking technology with a full care team.”

Beyond acute pain relief, the program employs an AI-powered platform to help members identify and manage their unique migraine triggers. Users can track environmental, lifestyle, and dietary factors, with the system providing personalized insights to help them understand patterns and make proactive changes. This is paired with expert-led care from a team of coaches and clinicians who provide guidance on exercise therapy and lifestyle modifications aimed at reducing the frequency and severity of future attacks.

The $78 Billion Headache: Why Employers Are Taking Notice

The financial burden of migraine is staggering. Individuals with the condition drive over $16,000 in annual medical and pharmaceutical spending—more than double that of those without it. For employers, this translates not only to higher healthcare costs but also to significant productivity losses. It is this compelling business case that has driven rapid early adoption of Hinge Health’s new offering.

Even before its official rollout in May 2026, the company reports that more than 125 clients, collectively covering over two million employees, have signed on for the Migraine Care Program. This strong pre-launch demand suggests employers are actively searching for more effective and cost-efficient ways to support employees with this condition.

“We’re excited to introduce this Migraine Care Program especially because our employees consistently share positive experiences with Hinge Health’s offerings,” said Rachel Harrell, Manager of Benefits Strategy for Sodexo, a global food and facilities management company. “We’re committed to expanding benefits that truly make a difference."

Much of this employer confidence is built on Hinge Health’s established track record in the MSK space. Multiple third-party validated studies of its digital physical therapy programs have demonstrated a significant return on investment for clients. A recent analysis, for instance, showed average savings of $2,343 per member per year on chronic MSK conditions, resulting in a 2.4x ROI for employers. These savings were largely driven by reductions in costly medical interventions, including a documented decrease in spinal, knee, and hip surgeries. With approximately 75% of migraine sufferers also reporting MSK pain, employers see a unique opportunity to address overlapping conditions through a single, trusted vendor.

A Blueprint for Digital Health's Future?

Hinge Health’s foray into migraine management is more than just a product launch; it represents a potential blueprint for the future of digital health. The strategy of building a robust, scalable platform for one chronic condition (MSK pain) and then leveraging that technology, clinical model, and client base to expand into adjacent conditions could become a playbook for the industry.

This move highlights a broader trend toward integrated, whole-person care. By recognizing the "meaningful overlap" in clinical best practices for MSK and migraine care, the company is breaking down traditional silos between physical and neurological health. Its model, which combines a medical device, AI-driven personalization, and human coaching, exemplifies a shift towards more data-driven, accessible, and patient-centered healthcare.

As digital health companies mature, the ability to address multiple chronic conditions under one umbrella is becoming a key differentiator. It simplifies benefits administration for employers and provides a more seamless experience for members who often suffer from more than one ailment. By proving it can successfully apply its core methodology to a new and complex condition like migraine, Hinge Health is not only expanding its market but also making a powerful statement about the scalability and adaptability of its digital care model. The success of this launch will be closely watched as a bellwether for the next phase of evolution in chronic disease management.